Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-11

Clinical Trial Update: Steroid Free Immunosuppression or Calcineurin Inhibitor Minimization After Basiliximab Induction Therapy in Kidney Transplantation: Comparison With a Standard Quadruple Immunosuppressive Regimen [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing steroid-free immunosuppression or calcineurin inhibitor minimization after basiliximab induction with a standard quadruple regi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Basiliximab (basiliximab)
  • Calcineurin inhibitors

Snippet

Sponsor: University Medical Center Groningen | Conditions: Renal Insufficiency, Kidney Transplantation | Phase 4 | Status: COMPLETED